NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qnovia

Qnovia

Private
Richmond, VirginiaHealthcare & Life Scienceshttps://www.qnovia.com/

Last Round

Series B

Dec 10, 2024

Est. Valuation

$300M

Total Funding Raised

$35.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Qnovia is a pharmaceutical and medtech company that develops proprietary inhalation device technologies and drug delivery platforms to improve patient outcomes, with an initial focus on smoking cessation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Patient Engagement, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

smoking cessationnicotine replacement therapyNRTvibrating mesh nebulizerinhaled drug deliverydrug-device combinationdigital healthmedtechbehavioral interventionpatient adherencesmart inhalerhealth IoTAI-powered coachingprescription digital therapeuticsPDT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qnovia Comps

Public and private peers based on sector, stage, and business model.

Qnovia comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qnovia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 10, 2024
Series ASep 28, 2022
SeedJan 13, 2020

Key People

Founding team and executive leadership

Brian Quigley

Principal Chief Executive Officer

Executive Team

Mario Danek

Founder CEO

Founding Team

James Watson

Chief Operating Officer

Executive Team

Qnovia Investors

Notable investors and investment history

Qnovia investors
InvestorRounds
Vice VenturesSeries A, Series B
Poseidon Asset ManagementSeed
Compass Rose Asset ManagementSeries B
GaingelsSeries A, Series B
Blue Ledge CapitalSeries A, Series B
DG VenturesSeries A, Seed
Third Lake CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors grew 164% MoM.

Qnovia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qnovia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qnovia's valuation, stock price, and market status.

Firmographic Details

HeadquartersRichmond, Virginia
Employee Range13
Year Founded2018
Last FundingDec 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.